ID: ALA3814751

Max Phase: Preclinical

Molecular Formula: C20H16N2O

Molecular Weight: 300.36

Molecule Type: Small molecule

Representations

Canonical SMILES:  N#Cc1ccccc1-c1ccc(CNc2ccc(O)cc2)cc1

Standard InChI:  InChI=1S/C20H16N2O/c21-13-17-3-1-2-4-20(17)16-7-5-15(6-8-16)14-22-18-9-11-19(23)12-10-18/h1-12,22-23H,14H2

Standard InChI Key:  JGOOJNWFTRVCQX-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 300.36

Molecular Weight (Monoisotopic): 300.1263

AlogP: 4.54

#Rotatable Bonds: 4

Polar Surface Area: 56.05

Molecular Species: NEUTRAL

HBA: 3

HBD: 2

#RO5 Violations: 0

HBA (Lipinski): 3

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 10.34

CX Basic pKa: 5.30

CX LogP: 4.37

CX LogD: 4.37

Aromatic Rings: 3

Heavy Atoms: 23

QED Weighted: 0.70

Np Likeness Score: -0.88

References

1. Khan FA, Patil RH, Shinde DB, Sangshetti JN..  (2016)  Bacterial Peptide deformylase inhibition of cyano substituted biaryl analogs: Synthesis, in vitro biological evaluation, molecular docking study and in silico ADME prediction.,  24  (16): [PMID:27269198] [10.1016/j.bmc.2016.05.051]

Source

Source(1):

• Scientific Literature